Figure 7. Summary of mechanisms of chNKG2D T cell-mediated anti-tumor angiogenesis.
Inside the tumor, chNKG2D T cells can directly target NKG2D ligand-positive tumor cells, tumor vasculature as well as angiogenesis-promoting MDSC and Treg, leading to less angiogenesis and reduced tumor growth. Both chNKG2D T cell-derived IFN-γ and perforin are involved in the inhibition. See text for details.
